Persones / Equip Humà

Rosana Hernando Salvador

Buscador de publicacions

Publicacions

  • Escalona López, Sergio Vidal, Haddi, Zouhair, Lores L, Vinyets J, Gresle, Anne Sophie, de Rosis, Sabrina and Hernando R.

    Evaluating a digital health ecosystem for asthma and air quality: an early feasibility study based on clinicians and patient-reported measures

    Frontiers in Digital Health . 8: 1766023-1766023.

    [doi:10.3389/fdgth.2026.1766023]

  • Pesantes E, Hernando R, Lores C, Cámara J, Arévalo E and Lores L.

    Utility of exhaled nitric oxide to guide mild asthma treatment in atopic patients and its correlation with asthma control test score: a randomized controlled trial

    BMC Pulmonary Medicine . 24(1): 421-421. Nº de cites: 2

    [doi:10.1186/s12890-024-03227-y]

  • Orriols R, Hernando R, Adelaida Ferrer Marcelles, Terradas S and Montoro B.

    Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.

    RESPIRATION . 90(4): 299-305. Nº de cites: 65

    [doi:10.1159/000438490]

  • Orriols R, Núñez V, Hernando R, Drobnic E and Moreiras M.

    Hemoptisis amenazante: estudio de 154 pacientes.

    MEDICINA CLINICA . 139(6): 255-260. Nº de cites: 4

    [doi:10.1016/j.medcli.2012.01.031]

  • Hernando R, Drobnic ME, Cruz MJ, Adelaida Ferrer Marcelles, Suñé P, Montoro JB and Orriols R.

    Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis.

    International Journal of Clinical Pharmacy . 34(4): 644-650. Nº de cites: 35

    [doi:10.1007/s11096-012-9659-6]

  • Roig J, Hernando R and Mora R.

    Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.

    Open Respiratory Medicine Journal . 3: 27-30.

    [doi:10.2174/1874306400903010027]